BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, Kulikova M, Deshpande V, Pillai S, Stone JH. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190-195. [PMID: 24817416 DOI: 10.1136/annrheumdis-2014-205233] [Cited by in Crossref: 258] [Cited by in F6Publishing: 218] [Article Influence: 32.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Yin W, Westerberg LS, Lee P, Gong Q, Chen Y, Dong L, Liu C. Immune Dysregulation in IgG4-Related Disease. Front Immunol 2021;12:738540. [PMID: 34539675 DOI: 10.3389/fimmu.2021.738540] [Reference Citation Analysis]
2 Fok JS, Katelaris CH. Angioedema Masqueraders. Clin Exp Allergy 2019;49:1274-82. [PMID: 31310036 DOI: 10.1111/cea.13463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Luo X, Peng Y, Zhang P, Li J, Liu Z, Lu H, Zhang X, Zeng X, Zhang F, Fei Y, Zhang W. Comparison of the Effects of Cyclophosphamide and Mycophenolate Mofetil Treatment Against Immunoglobulin G4-Related Disease: A Retrospective Cohort Study. Front Med (Lausanne) 2020;7:253. [PMID: 32733900 DOI: 10.3389/fmed.2020.00253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Zhu J, Zhang Y, Shi L, Xia Y, Zha H, Li H, Song Z. RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathways. Int Immunopharmacol 2022;109:108904. [PMID: 35696803 DOI: 10.1016/j.intimp.2022.108904] [Reference Citation Analysis]
5 Touzani F, Pozdzik A. New insights into immune cells cross-talk during IgG4-related disease. Clin Immunol 2019;198:1-10. [PMID: 30419354 DOI: 10.1016/j.clim.2018.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Bozzalla Cassione E, Stone JH. IgG4-related disease. Curr Opin Rheumatol. 2017;29:223-227. [PMID: 28319486 DOI: 10.1097/bor.0000000000000383] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
7 Kamekura R, Takano K, Yamamoto M, Kawata K, Shigehara K, Jitsukawa S, Nagaya T, Ito F, Sato A, Ogasawara N, Tsubomatsu C, Takahashi H, Nakase H, Himi T, Ichimiya S. Cutting Edge: A Critical Role of Lesional T Follicular Helper Cells in the Pathogenesis of IgG4-Related Disease. J Immunol. 2017;199:2624-2629. [PMID: 28916523 DOI: 10.4049/jimmunol.1601507] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
8 Berti A, Della-torre E, Gallivanone F, Canevari C, Milani R, Lanzillotta M, Campochiaro C, Ramirez GA, Bozzalla Cassione E, Bozzolo E, Pedica F, Castiglioni I, Arcidiacono PG, Balzano G, Falconi M, Gianolli L, Dagna L. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease. Rheumatology 2017;56:2084-92. [DOI: 10.1093/rheumatology/kex234] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
9 Ishigami K, Shitani M, Kimura Y, Hasegawa T, Masaki Y, Ito A, Akutsu N, Yamamoto M, Motoya M, Sasaki S, Takahashi H, Takemasa I, Nakase H. Ectopic relapse of IgG4-related disease presenting as IgG4-related sclerosing cholecystitis: A case report and review of literature. Medicine (Baltimore) 2018;97:e13868. [PMID: 30593191 DOI: 10.1097/MD.0000000000013868] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
10 Koarada S, Tada Y. Roles of plasmablasts in IgG4-related disease and various immune-based diseases. World J Rheumatol 2016; 6(1): 16-22 [DOI: 10.5499/wjr.v6.i1.16] [Reference Citation Analysis]
11 Zhang P, Cornell LD. IgG4-Related Tubulointerstitial Nephritis. Adv Chronic Kidney Dis 2017;24:94-100. [PMID: 28284385 DOI: 10.1053/j.ackd.2016.12.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
12 Ramadass T, Balaji V, Sheba SKJ, Vali Ahmed KS, Abdurahiman R. IgG4-Related Disease (IgG4-RD) Presenting as a Mass in the Carotid Triangle Masquerading Paraganglioma. Indian J Otolaryngol Head Neck Surg 2017;69:259-62. [PMID: 28607901 DOI: 10.1007/s12070-016-0976-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Fujita Y, Fukui S, Umeda M, Tsuji S, Iwamoto N, Nakashima Y, Horai Y, Suzuki T, Okada A, Aramaki T, Ueki Y, Mizokami A, Origuchi T, Watanabe H, Migita K, Kawakami A. Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia. Front Immunol 2022;13:828122. [PMID: 35296071 DOI: 10.3389/fimmu.2022.828122] [Reference Citation Analysis]
14 Löhr JM, Beuers U, Vujasinovic M, Alvaro D, Frøkjær JB, Buttgereit F, Capurso G, Culver EL, de-Madaria E, Della-Torre E, Detlefsen S, Dominguez-Muñoz E, Czubkowski P, Ewald N, Frulloni L, Gubergrits N, Duman DG, Hackert T, Iglesias-Garcia J, Kartalis N, Laghi A, Lammert F, Lindgren F, Okhlobystin A, Oracz G, Parniczky A, Mucelli RMP, Rebours V, Rosendahl J, Schleinitz N, Schneider A, van Bommel EF, Verbeke CS, Vullierme MP, Witt H; UEG guideline working group. European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J 2020;8:637-66. [PMID: 32552502 DOI: 10.1177/2050640620934911] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 26.5] [Reference Citation Analysis]
15 Della-Torre E, Rigamonti E, Perugino C, Baghai-Sain S, Sun N, Kaneko N, Maehara T, Rovati L, Ponzoni M, Milani R, Lanzillotta M, Mahajan V, Mattoo H, Molineris I, Deshpande V, Stone JH, Falconi M, Manfredi AA, Pillai S. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol. 2020;145:968-981.e14. [PMID: 31319101 DOI: 10.1016/j.jaci.2019.07.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
16 Wallwork R, Wallace Z, Perugino C, Sharma A, Stone JH. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Medicine (Baltimore) 2018;97:e12631. [PMID: 30334947 DOI: 10.1097/MD.0000000000012631] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Löhr JM, Vujasinovic M, Rosendahl J, Stone JH, Beuers U. IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34750548 DOI: 10.1038/s41575-021-00529-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Lanzillotta M, Fernàndez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E. Emerging therapy options for IgG4-related disease. Expert Rev Clin Immunol 2021;17:471-83. [PMID: 33689549 DOI: 10.1080/1744666X.2021.1902310] [Reference Citation Analysis]
19 Yamamoto M, Takahashi H, Takano K, Himi T, Nakase H. Response to: 'Could abatacept directly target expanded plasmablasts in IgG4-related disease?' by Alegria et al. Ann Rheum Dis. 2016;75:e74. [PMID: 27651399 DOI: 10.1136/annrheumdis-2016-210403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Deshpande V. IgG4 related disease of the head and neck. Head Neck Pathol 2015;9:24-31. [PMID: 25804380 DOI: 10.1007/s12105-015-0620-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
21 Baenas DF, Miretti VS, Caeiro F, Paira S. Differential diagnosis between pancreatic involvement in IgG4-related disease and pancreatic cancer. Gastroenterol Hepatol 2021;44:144-55. [PMID: 32718841 DOI: 10.1016/j.gastrohep.2020.05.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Witte T. [Immunological principles of IgG4 related diseases]. Radiologe 2016;56:1043-8. [PMID: 27832299 DOI: 10.1007/s00117-016-0188-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
23 Albitar HAH, Carmona EM. 48-Year-Old Man With Bilateral Mediastinal Lymphadenopathy, Orbital Pseudotumors, Kidney Masses, and Acute Pancreatitis. Mayo Clin Proc 2019;94:531-5. [PMID: 30713047 DOI: 10.1016/j.mayocp.2018.05.037] [Reference Citation Analysis]
24 Haldar D, Hirschfield GM. Deciphering the biology of IgG4-related disease: specific antigens and disease? Gut 2018;67:602-5. [PMID: 29101259 DOI: 10.1136/gutjnl-2017-314861] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
25 Lin W, Zhang P, Chen H, Chen Y, Yang H, Zheng W, Zhang X, Zhang F, Zhang W, Lipsky PE. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther 2017;19:25. [PMID: 28183334 DOI: 10.1186/s13075-017-1231-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 11.2] [Reference Citation Analysis]
26 Liu H, Perugino CA, Ghebremichael M, Wallace ZS, Montesi SB, Stone JH, Pillai S. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease. Arthritis Rheumatol 2020;72:687-93. [PMID: 31612628 DOI: 10.1002/art.41140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
27 Culver EL, Vermeulen E, Makuch M, van Leeuwen A, Sadler R, Cargill T, Klenerman P, Aalberse RC, van Ham SM, Barnes E, Rispens T. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann Rheum Dis. 2015;74:944-947. [PMID: 25646372 DOI: 10.1136/annrheumdis-2014-206405] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
28 Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M. Diagnostic Approach to the Complexity of IgG4-Related Disease. Mayo Clin Proc 2015;90:927-39. [PMID: 26141331 DOI: 10.1016/j.mayocp.2015.03.020] [Cited by in Crossref: 107] [Cited by in F6Publishing: 86] [Article Influence: 15.3] [Reference Citation Analysis]
29 Della Torre E. IgG4-Related Disease. In: Dammacco F, Ribatti D, Vacca A, editors. Systemic Vasculitides: Current Status and Perspectives. Cham: Springer International Publishing; 2016. pp. 311-20. [DOI: 10.1007/978-3-319-40136-2_27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Xiao X, Lian M, Zhang W, Eric Gershwin M, Ma X. The Immunologic Paradoxes of IgG4-Related Disease. Clin Rev Allergy Immunol. 2018;54:344-351. [PMID: 29460058 DOI: 10.1007/s12016-018-8679-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
31 Koarada S, Tashiro S, Tokuda Y, Ono Y, Sadanaga Y, Suematsu R, Ono N, Ohta A, Tada Y. Persistent expression of CXCR5 on plasmablasts in IgG4-related disease. Ann Rheum Dis. 2015;74:e32. [PMID: 25603828 DOI: 10.1136/annrheumdis-2014-207207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Greenfield AL, Hauser SL. B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol 2018;83:13-26. [PMID: 29244240 DOI: 10.1002/ana.25119] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 32.0] [Reference Citation Analysis]
33 De Sainte Marie B, Urban ML, Vély F, Seguier J, Grados A, Daniel L, Ebbo M, Schleinitz N. Pathophysiology of IgG4-related disease: A T follicular helper cells disease? Presse Med 2020;49:104013. [PMID: 32234383 DOI: 10.1016/j.lpm.2020.104013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T. Pathogenesis of IgG4-related disease. Comparison with Sjögren's syndrome. Mod Rheumatol 2020;30:7-16. [PMID: 31425659 DOI: 10.1080/14397595.2019.1650694] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Beuers U, Gershwin ME. Unmet challenges in immune-mediated hepatobiliary diseases. Clin Rev Allergy Immunol 2015;48:127-31. [PMID: 25820618 DOI: 10.1007/s12016-015-8484-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sokol EV. [IgG4-related disease: what do we know after 20 years]. Ter Arkh 2020;92:104-9. [PMID: 32598782 DOI: 10.26442/00403660.2020.05.000632] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Olejarz M, Szczepanek-Parulska E, Dadej D, Sawicka-Gutaj N, Domin R, Ruchała M. IgG4 as a Biomarker in Graves' Orbitopathy. Mediators Inflamm 2021;2021:5590471. [PMID: 34220335 DOI: 10.1155/2021/5590471] [Reference Citation Analysis]
38 Waheed W, Skidd PM, Borden NM, Gibson PC, Babi MA, Tandan R. Metachronous Involvement, Diagnostic Imprecision of Serum Immunoglobulin G4 Levels, and Discordance Between Clinical and Radiological Findings in Immunoglobulin G4–Related Pachymeningitis: A Longitudinal Case Report. JCR: Journal of Clinical Rheumatology 2017;23:215-21. [DOI: 10.1097/rhu.0000000000000488] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Kubo S, Nakayamada S, Tanaka Y. Immunophenotype involved in IgG4-related disease. Mod Rheumatol. 2019;29:226-230. [PMID: 30334637 DOI: 10.1080/14397595.2018.1537962] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Soares C, Martins DF, Pestana-silva R, Honavar M, Faria O, Abreu P, Costa A. Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis. Journal of Neuroimmunology 2019;334:576997. [DOI: 10.1016/j.jneuroim.2019.576997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67:1688-1699. [PMID: 25809420 DOI: 10.1002/art.39132] [Cited by in Crossref: 467] [Cited by in F6Publishing: 379] [Article Influence: 66.7] [Reference Citation Analysis]
42 Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart PA, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken) 2018;70:1671-8. [PMID: 29457382 DOI: 10.1002/acr.23543] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 17.3] [Reference Citation Analysis]
43 Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, van Laar J. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J 2016;14:18. [PMID: 27012661 DOI: 10.1186/s12969-016-0079-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
44 Sah RP, Chari ST. Recent developments in steroid-responsive pancreatitides (autoimmune pancreatitis). Curr Opin Gastroenterol 2015;31:387-94. [PMID: 26154429 DOI: 10.1097/MOG.0000000000000205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Martínez-valle F, Fernández-codina A, Pinal-fernández I, Orozco-gálvez O, Vilardell-tarrés M. IgG4-related disease: Evidence from six recent cohorts. Autoimmunity Reviews 2017;16:168-72. [DOI: 10.1016/j.autrev.2016.12.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
46 Raess PW, Habashi A, El Rassi E, Milas M, Sauer DA, Troxell ML. Overlapping Morphologic and Immunohistochemical Features of Hashimoto Thyroiditis and IgG4-Related Thyroid Disease. Endocr Pathol 2015;26:170-7. [PMID: 25898816 DOI: 10.1007/s12022-015-9368-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
47 Mulay K, Wick MR. Ophthalmic immunoglobulin G4-related disease IgG4-RD Current concepts. Seminars in Diagnostic Pathology 2016;33:148-55. [DOI: 10.1053/j.semdp.2015.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
48 Puxeddu I, Capecchi R, Carta F, Tavoni AG, Migliorini P, Puxeddu R. Salivary Gland Pathology in IgG4-Related Disease: A Comprehensive Review. J Immunol Res 2018;2018:6936727. [PMID: 29805984 DOI: 10.1155/2018/6936727] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
49 Shakeri A, Kindley KJ, Noland MM, Gru AA. IgG4-Related Skin Disease Presenting as a Pseudolymphoma in a White Adolescent Girl. Am J Dermatopathol 2019;41:675-9. [PMID: 30839348 DOI: 10.1097/DAD.0000000000001401] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
50 Betancur-Vásquez L, Gonzalez-Hurtado D, Arango-Isaza D, Rojas-Villarraga A, Hernandez-Parra D, Carmona S, Díaz-Coronado JC. IgG4-related disease: Is rituximab the best therapeutic strategy for cases refractory to conventional therapy? Results of a systematic review. Reumatol Clin (Engl Ed) 2020;16:195-202. [PMID: 30665856 DOI: 10.1016/j.reuma.2018.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Detlefsen S, Klöppel G. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis. Virchows Arch 2018;472:545-56. [PMID: 29196804 DOI: 10.1007/s00428-017-2275-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
52 Martínez-Valle F, Orozco-Gálvez O, Fernández-Codina A. Update in ethiopathogeny, diagnosis and treatment of the IgG4 related disease. Med Clin (Barc) 2018;151:18-25. [PMID: 29241876 DOI: 10.1016/j.medcli.2017.10.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Watanabe T, Yamashita K, Kudo M. IgG4-Related Disease and Innate Immunity. Curr Top Microbiol Immunol 2017;401:115-28. [PMID: 27744509 DOI: 10.1007/82_2016_42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
54 Maehara T, Pillai S, Stone JH, Nakamura S. Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review. Int J Oral Maxillofac Surg 2019;48:908-16. [PMID: 30686634 DOI: 10.1016/j.ijom.2019.01.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Della-Torre E, Campochiaro C, Cassione EB, Albano L, Gerevini S, Bianchi-Marzoli S, Bozzolo E, Passerini G, Lanzillotta M, Terreni M, Callea M, Trimarchi M, Mortini P, Tresoldi M, Acerno S, Dagna L. Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis. J Neurol Neurosurg Psychiatry 2018;89:441-4. [PMID: 28819060 DOI: 10.1136/jnnp-2017-316519] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
56 Carvajal Alegria G, Pochard P, Pers J, Cornec D. Could abatacept directly target expanded plasmablasts in IgG4-related disease? Ann Rheum Dis 2016;75:e73-e73. [DOI: 10.1136/annrheumdis-2016-210400] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
57 Capecchi R, Croia C, Puxeddu I, Pratesi F, Cacciato A, Campani D, Boggi U, Morelli L, Tavoni A, Migliorini P. CXCL12/SDF-1 in IgG4-Related Disease. Front Pharmacol 2021;12:750216. [PMID: 34764871 DOI: 10.3389/fphar.2021.750216] [Reference Citation Analysis]
58 Sutton BJ, Davies AM, Bax HJ, Karagiannis SN. IgE Antibodies: From Structure to Function and Clinical Translation. Antibodies (Basel) 2019;8:E19. [PMID: 31544825 DOI: 10.3390/antib8010019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
59 Mcnab AA, Mckelvie P. IgG4-Related Ophthalmic Disease. Part I: Background and Pathology. Ophthalmic Plastic & Reconstructive Surgery 2015;31:83-8. [DOI: 10.1097/iop.0000000000000363] [Cited by in Crossref: 47] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
60 Perugino CA, Mattoo H, Mahajan VS, Maehara T, Wallace ZS, Pillai S, Stone JH. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol 2017;69:1722-32. [PMID: 28575535 DOI: 10.1002/art.40168] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
61 Lanzillotta M, Della-Torre E, Milani R, Bozzolo E, Bozzalla-Cassione E, Rovati L, Arcidiacono PG, Partelli S, Falconi M, Ciceri F, Dagna L. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse. Arthritis Res Ther 2018;20:222. [PMID: 30285841 DOI: 10.1186/s13075-018-1718-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
62 von Borstel A, Land J, Abdulahad WH, Rutgers A, Stegeman CA, Diepstra A, Heeringa P, Sanders JS. CD27+CD38hi B Cell Frequency During Remission Predicts Relapsing Disease in Granulomatosis With Polyangiitis Patients. Front Immunol 2019;10:2221. [PMID: 31608054 DOI: 10.3389/fimmu.2019.02221] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
63 Hart PA, Zen Y, Chari ST. Recent Advances in Autoimmune Pancreatitis. Gastroenterology 2015;149:39-51. [DOI: 10.1053/j.gastro.2015.03.010] [Cited by in Crossref: 139] [Cited by in F6Publishing: 102] [Article Influence: 19.9] [Reference Citation Analysis]
64 Vitkovski T, Marder GS, Filardi DA, Gupta E, Breuer F. IgG4-Related Sclerosing Disease of the Breast in a Male Patient. Int J Surg Pathol 2017;25:711-5. [PMID: 28612666 DOI: 10.1177/1066896917714324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
65 Thompson A, Whyte A. Imaging of IgG4-related disease of the head and neck. Clin Radiol 2018;73:106-20. [PMID: 28501095 DOI: 10.1016/j.crad.2017.04.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
66 Zhang P, Gong Y, Liu Z, Liu Y, Lin W, Li J, Wang M, Liu X, Fei Y, Chen H, Peng L, Li J, Zhou J, Shi Q, Zhang X, Shen M, Zeng X, Zhang F, Li Y, Zhao Y, Zhang W. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial. Int J Rheum Dis 2019;22:1479-88. [PMID: 31245907 DOI: 10.1111/1756-185X.13633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
67 Yukina MY, Troshina EA, Platonova NM, Nuralieva NF. The autoimmune IgG4 -associated endocrine pathology. Obes metabol 2017;14:43-7. [DOI: 10.14341/omet2017343-47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, Bazzigaluppi E, Canevari C, Modorati G, Stone JH, Manfredi A, Doglioni C. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: A case report and review of the literature. Medicine (Baltimore) 2016;95:e4633. [PMID: 27559962 DOI: 10.1097/MD.0000000000004633] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
69 Zhang P, Zhang Y, Pan M, Liu Z, Li J, Peng L, Zhou J, Hu C, Liu S, Zeng X, Ge W, Zhang W. Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage. J Autoimmun 2021;122:102650. [PMID: 34107438 DOI: 10.1016/j.jaut.2021.102650] [Reference Citation Analysis]
70 Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM. Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol 2017;19:14. [PMID: 28374231 DOI: 10.1007/s11940-017-0450-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
71 Takano K, Yamamoto M, Takahashi H, Himi T. Recent advances in knowledge regarding the head and neck manifestations of IgG4-related disease. Auris Nasus Larynx 2017;44:7-17. [PMID: 27956101 DOI: 10.1016/j.anl.2016.10.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
72 Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol 2016;68:2283-9. [PMID: 27273903 DOI: 10.1002/art.39773] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 11.4] [Reference Citation Analysis]
73 Zheng K, Teng F, Li XM. Immunoglobulin G4-related kidney disease: Pathogenesis, diagnosis, and treatment. Chronic Dis Transl Med 2017;3:138-47. [PMID: 29063068 DOI: 10.1016/j.cdtm.2017.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
74 Delgado-garcía G, Sánchez-salazar S, Rendón-ramírez E, Castro-medina M, Sáenz-ibarra B, Barboza-quintana Á, Loredo-alanis MA, Hernández-barajas D, Galarza-delgado D. Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review. Clin Rheumatol 2016;35:2857-64. [DOI: 10.1007/s10067-016-3292-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
75 Otani K, Inoue D, Fujikura K, Komori T, Abe-Suzuki S, Tajiri T, Itoh T, Zen Y. Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 2018;9:6691-706. [PMID: 29467920 DOI: 10.18632/oncotarget.24068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
76 Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. [PMID: 32546500 DOI: 10.1136/bmj.m1067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
77 Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015;67:2466-2475. [PMID: 25988916 DOI: 10.1002/art.39205] [Cited by in Crossref: 289] [Cited by in F6Publishing: 254] [Article Influence: 41.3] [Reference Citation Analysis]
78 Cai S, Chen Y, Lin S, Ye C, Zheng F, Dong L. Multiple Processes May Involve in the IgG4-RD Pathogenesis: An Integrative Study via Proteomic and Transcriptomic Analysis. Front Immunol 2020;11:1795. [PMID: 32973752 DOI: 10.3389/fimmu.2020.01795] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients: IgG4-RELATED DISEASE IN NON-ASIAN POPULATIONS. Arthritis & Rheumatology 2016;68:2290-9. [DOI: 10.1002/art.39686] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
80 Rzepecka A, Babińska A, Sworczak K. IgG4-related disease in endocrine practice. Arch Med Sci 2019;15:55-64. [PMID: 30697253 DOI: 10.5114/aoms.2017.70889] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
81 Tokura Y, Yagi H, Yanaguchi H, Majima Y, Kasuya A, Ito T, Maekawa M, Hashizume H. IgG4‐related skin disease. Br J Dermatol 2014;171:959-67. [DOI: 10.1111/bjd.13296] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 8.6] [Reference Citation Analysis]
82 Della-Torre E, Bozzalla-Cassione E, Sciorati C, Ruggiero E, Lanzillotta M, Bonfiglio S, Mattoo H, Perugino CA, Bozzolo E, Rovati L, Arcidiacono PG, Balzano G, Lazarevic D, Bonini C, Falconi M, Stone JH, Dagna L, Pillai S, Manfredi AA. A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment. Arthritis Rheumatol 2018;70:1133-43. [PMID: 29499100 DOI: 10.1002/art.40469] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
83 Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity 2017;50:19-24. [PMID: 28166682 DOI: 10.1080/08916934.2017.1280029] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
84 Pomponio G, Olivari D, Mattioli M, Angeletti A, Rossetti G, Goteri G, Gabrielli A. Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report. Medicine (Baltimore) 2018;97:e11143. [PMID: 29952960 DOI: 10.1097/MD.0000000000011143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
85 Zhou Y, Shao L, Ruan W, Jin J, Xu H, Ying K, Wu X. Pulmonary vascular involvement of IgG4-related disease: Case series with a PRISMA-compliant systemic review. Medicine (Baltimore) 2019;98:e14437. [PMID: 30732204 DOI: 10.1097/MD.0000000000014437] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
86 Yamada K, Mizushima I, Kawano M. New insights into the pathophysiology of IgG4-related disease and markers of disease activity. Expert Rev Clin Immunol 2019;15:231-9. [PMID: 30557078 DOI: 10.1080/1744666X.2019.1560268] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Chen Y, Zhao JZ, Feng RE, Shi JH, Li XM, Fei YY, Shi Y, Zhang W, Zhang FC. Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease. Chin Med J (Engl) 2016;129:1525-32. [PMID: 27364787 DOI: 10.4103/0366-6999.184459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
88 Stone JH, Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S. Response to: ‘Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years’ by Yamamoto et al. Ann Rheum Dis 2015;74:e47-e47. [DOI: 10.1136/annrheumdis-2015-207640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
89 Yu Y, Lv L, Yin SL, Chen C, Jiang S, Zhou PZ. Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report. World J Clin Cases 2022; 10(18): 6269-6276 [DOI: 10.12998/wjcc.v10.i18.6269] [Reference Citation Analysis]
90 Perugino CA, AlSalem SB, Mattoo H, Della-Torre E, Mahajan V, Ganesh G, Allard-Chamard H, Wallace Z, Montesi SB, Kreuzer J, Haas W, Stone JH, Pillai S. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol 2019; 143: 736-745. e6. [PMID: 29852256 DOI: 10.1016/j.jaci.2018.05.011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 15.0] [Reference Citation Analysis]
91 Simon NL, Negmeldin M. IgG4-related disease: a great mimicker of lung cancer. BMJ Case Rep 2021;14:e239976. [PMID: 33622751 DOI: 10.1136/bcr-2020-239976] [Reference Citation Analysis]
92 Yadlapati S, Verheyen E, Efthimiou P. IgG4-related disease: a complex under-diagnosed clinical entity. Rheumatol Int 2018;38:169-77. [PMID: 28681251 DOI: 10.1007/s00296-017-3765-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
93 Chan ASY, Mudhar H, Shen SY, Lang SS, Fernando M, Hilmy MH, Guppy NJ, Rennie I, Dunkley L, Al Jajeh I. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment. Br J Ophthalmol. 2017;101:1576-1582. [PMID: 28351925 DOI: 10.1136/bjophthalmol-2017-310148] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
94 Nguyen Canh H, Harada K. Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma. Med Mol Morphol. 2016;49:189-202. [PMID: 27350291 DOI: 10.1007/s00795-016-0143-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
95 Zen Y, Kawakami H, Kim JH. IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol. 2016;51:295-312. [PMID: 26817943 DOI: 10.1007/s00535-016-1163-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
96 Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol 2016;13:601-12. [DOI: 10.1038/nrgastro.2016.132] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
97 Varghese JL, Fung AWS, Mattman A, Quach TTT, Gauiran DTV, Carruthers MN, Chen LYC. Clinical utility of serum IgG4 measurement. Clin Chim Acta 2020;506:228-35. [PMID: 32272158 DOI: 10.1016/j.cca.2020.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
98 Mcnab AA, Mckelvie P. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects. Ophthalmic Plastic & Reconstructive Surgery 2015;31:167-78. [DOI: 10.1097/iop.0000000000000364] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 8.1] [Reference Citation Analysis]
99 Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, Kassai Y, Koga K, Miyazaki T, Morita R. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther. 2016;18:167. [PMID: 27411315 DOI: 10.1186/s13075-016-1064-4] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 14.7] [Reference Citation Analysis]
100 Pelaez-Luna M, Soriano-Rios A, Lira-Treviño AC, Uscanga-Domínguez L. Steroid-responsive pancreatitides. World J Clin Cases 2020; 8(16): 3411-3430 [PMID: 32913848 DOI: 10.12998/wjcc.v8.i16.3411] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Cargill T, Culver EL. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Front Immunol 2021;12:661196. [PMID: 33936097 DOI: 10.3389/fimmu.2021.661196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Katerji R, Smoller BR. Immunoglobulin-G4-related skin disease. Clin Dermatol 2021;39:283-90. [PMID: 34272023 DOI: 10.1016/j.clindermatol.2020.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Rumyantsev PO, Kozlov IG, Kolpakova EA, Chukhacheva OS, Korenev SV, Goncharov AG, Ulanova EU. [IGG4-related diseases in endocrinology]. Probl Endokrinol (Mosk) 2020;66:24-32. [PMID: 33351345 DOI: 10.14341/probl12285] [Reference Citation Analysis]
104 Liu S, Wang H, Su T. Active IgG4-related disease with bone marrow involvement: a report of 2 cases and case-based review. Eur J Med Res 2022;27:17. [PMID: 35109941 DOI: 10.1186/s40001-022-00643-w] [Reference Citation Analysis]
105 Martin M, Wrotniak BH, Hicar M. Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease. PLoS One 2018;13:e0193539. [PMID: 29579044 DOI: 10.1371/journal.pone.0193539] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
106 Mombaerts I. The many facets of dacryoadenitis. Curr Opin Ophthalmol 2015;26:399-407. [PMID: 26247137 DOI: 10.1097/ICU.0000000000000183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
107 Beyer G, Hoffmeister A, Michl P, Gress TM, Huber W, Algül H, Neesse A, Meining A, Seufferlein TW, Rosendahl J, Kahl S, Keller J, Werner J, Friess H, Bufler P, Löhr MJ, Schneider A, Lynen Jansen P, Esposito I, Grenacher L, Mössner J, Lerch MM, Mayerle J; Collaborators:. S3-Leitlinie Pankreatitis – Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – September 2021 – AWMF Registernummer 021-003. Z Gastroenterol 2022;60:419-521. [PMID: 35263785 DOI: 10.1055/a-1735-3864] [Reference Citation Analysis]
108 Cargill T, Makuch M, Sadler R, Lighaam LC, Peters R, van Ham M, Klenerman P, Bateman A, Rispens T, Barnes E, Culver EL. Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis. Clin Transl Gastroenterol 2019;10:e00020. [DOI: 10.14309/ctg.0000000000000020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
109 Zhang J, Lian M, Li B, Gao L, Tanaka T, You Z, Wei Y, Chen Y, Li Y, Li Y, Huang B, Tang R, Wang Q, Miao Q, Peng Y, Fang J, Lian Z, Okazaki K, Xiao X, Zhang W, Ma X. Interleukin-35 Promotes Th9 Cell Differentiation in IgG4-Related Disorders: Experimental Data and Review of the Literature. Clin Rev Allergy Immunol 2021;60:132-45. [PMID: 32712804 DOI: 10.1007/s12016-020-08803-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
110 Kaneko N, Moriyama M, Maehara T, Chen H, Miyahara Y, Nakamura S. Orchestration of Immune Cells Contributes to Fibrosis in IgG4-Related Disease. Immuno 2022;2:170-84. [DOI: 10.3390/immuno2010013] [Reference Citation Analysis]
111 Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis 2016;19:1049-55. [PMID: 27125330 DOI: 10.1111/1756-185X.12863] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 4.2] [Reference Citation Analysis]
112 Feydorova TI, Vinokurova LV, Dvoynikov SY, Mikheeva OM, Dudin GA, Akopova AO. [Clinical case of IgG4-related disease in a patient with Burkitt lymphoma]. Ter Arkh 2019;91:100-5. [PMID: 32598742 DOI: 10.26442/00403660.2019.07.000069] [Reference Citation Analysis]
113 Nishida K, Gion Y, Takeuchi M, Tanaka T, Kataoka TR, Yoshino T, Sato Y. Mast Cells Exhibiting Strong Cytoplasmic Staining for IgE and High Affinity IgE Receptor are Increased in IgG4-Related Disease. Sci Rep 2018;8:4656. [PMID: 29545608 DOI: 10.1038/s41598-018-23043-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Unger PA, Lighaam LC, Vermeulen E, Kruithof S, Makuch M, Culver EL, van Bruggen R, Remmerswaal EBM, Ten Berge IJM, Emmens RW, Niessen HWM, Barnes E, Wolbink GJ, van Ham SM, Rispens T. Divergent chemokine receptor expression and the consequence for human IgG4 B cell responses. Eur J Immunol 2020;50:1113-25. [PMID: 32289181 DOI: 10.1002/eji.201948454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
115 Tan M, Li Z, Tang H, Sun G, Xu Z. IgG4-Related Tumefactive Lesions at the Pulmonary Artery Causing Stenosis of Bilateral Primary Branches and Resultant Pulmonary Hypertension. Cardiology 2019;143:136-44. [PMID: 31476758 DOI: 10.1159/000501741] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, Wallace ZS, Carruthers M, Chung RT, Pillai S, Stone JH. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis 2015;74:2236-43. [PMID: 25143523 DOI: 10.1136/annrheumdis-2014-205799] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 8.4] [Reference Citation Analysis]
117 Gummlich BP, Ströbel P, Seif Amir Hosseini A, Neesse A, Ellenrieder V, Schwörer H. Systemic IgG4-Related Disease Masquerading as Cholangiocarcinoma: A Case Report Underscoring the Importance of Medical History. Am J Case Rep 2021;22:e930729. [PMID: 34052827 DOI: 10.12659/AJCR.930729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Perugino CA, Stone JH. Treatment of IgG4-related disease : Current and future approaches. Z Rheumatol 2016;75:681-6. [PMID: 27431746 DOI: 10.1007/s00393-016-0142-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
119 Lindquist ME, Hicar MD. B Cells and Antibodies in Kawasaki Disease. Int J Mol Sci 2019;20:E1834. [PMID: 31013925 DOI: 10.3390/ijms20081834] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
120 Pozdzik A, Beukinga I, Gu-Trantien C, Willard-Gallo K, Nortier J, Pradier O. Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy? Mediators Inflamm 2016;2016:7651024. [PMID: 27493452 DOI: 10.1155/2016/7651024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
121 Deshpande V, Zane NA, Kraft S, Stone JH, Faquin WC. Recurrent Mastoiditis Mimics IgG4 Related Disease: A Potential Diagnostic Pitfall. Head Neck Pathol 2016;10:314-20. [PMID: 27091207 DOI: 10.1007/s12105-016-0710-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
122 Shiao JY, Chang YT, Chang MC, Chen MX, Liu LW, Wang XY, Tsai YJ, Kuo TC, Tsai IL. Development of efficient on-bead protein elution process coupled to ultra-high performance liquid chromatography-tandem mass spectrometry to determine immunoglobulin G subclass and glycosylation for discovery of bio-signatures in pancreatic disease. J Chromatogr A 2020;1621:461039. [PMID: 32295703 DOI: 10.1016/j.chroma.2020.461039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Takayama R, Ueno T, Saeki H. Immunoglobulin G4-related disease and its skin manifestations. J Dermatol 2017;44:288-96. [DOI: 10.1111/1346-8138.13723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
124 Kubo S, Nakayamada S, Zhao J, Yoshikawa M, Miyazaki Y, Nawata A, Hirata S, Nakano K, Saito K, Tanaka Y. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Rheumatology (Oxford). 2018;57:514-524. [PMID: 29253269 DOI: 10.1093/rheumatology/kex455] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
125 Dassanayaka W, Liyanaarachchi KS, Ala A, Bagwan IN. IgG4-related disease: an analysis of the clinicopathological spectrum: UK centre experience. J Clin Pathol 2021:jclinpath-2021-207748. [PMID: 34413088 DOI: 10.1136/jclinpath-2021-207748] [Reference Citation Analysis]
126 Obiorah IE, Henao Velasquez A, Özdemirli M. The Clinicopathologic Spectrum of IgG4-Related Disease. Balkan Med J 2018;35:292-300. [PMID: 29866638 DOI: 10.4274/balkanmedj.2018.0809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
127 Wick CC, Zachariah J, Manjila S, Brown WC, Malla P, Katirji B, Cohen M, Megerian CA. IgG4-related disease causing facial nerve and optic nerve palsies: Case report and literature review. Am J Otolaryngol 2016;37:567-71. [PMID: 27609186 DOI: 10.1016/j.amjoto.2016.08.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
128 Srinivasan A, Kleinberg TT, Murchison AP, Bilyk JR. Laboratory Investigations for Diagnosis of Autoimmune and Inflammatory Periocular Disease: Part I. Ophthalmic Plastic & Reconstructive Surgery 2016;32:321-8. [DOI: 10.1097/iop.0000000000000697] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Pieringer H, Parzer I, Wöhrer A, Reis P, Oppl B, Zwerina J. IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis 2014;9:110. [PMID: 25026959 DOI: 10.1186/s13023-014-0110-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
130 Peng L, Zhang P, Li J, Liu Z, Lu H, Zhu L, Wang X, Teng F, Li X, Guo H, Fei Y, Zhang W, Zhao Y, Zeng X, Zhang F. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease. Arthritis Res Ther 2020;22:103. [PMID: 32366271 DOI: 10.1186/s13075-020-02197-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
131 Williams MM, Mashaly H, Puduvalli VK, Jin M, Mendel E. Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. J Neurosurg Spine 2017;26:76-80. [PMID: 27517527 DOI: 10.3171/2016.5.SPINE16119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
132 Umehara H, Okazaki K, Kawano M, Mimori T, Chiba T. How to diagnose IgG4-related disease. Ann Rheum Dis 2017;76:e46. [PMID: 28283514 DOI: 10.1136/annrheumdis-2017-211330] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
133 Simopoulou T, Klimopoulos S, Sampaziotis D, Tzortziotis A, Bogdanos D, Sakkas LI. Inferior vena cava thrombosis as the initial presentation of IgG4-related retroperitoneal fibrosis: Case report and literature review. Journal of Scleroderma and Related Disorders 2018;3:NP1-6. [DOI: 10.1177/2397198318764793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
134 Zhang W, Stone JH. Management of IgG4-related disease. The Lancet Rheumatology 2019;1:e55-65. [DOI: 10.1016/s2665-9913(19)30017-7] [Cited by in Crossref: 33] [Article Influence: 11.0] [Reference Citation Analysis]
135 Blockmans D. IgG4-related disease. Acta Clin Belg 2018;73:11-5. [PMID: 29110571 DOI: 10.1080/17843286.2017.1396675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Heeringa JJ, Karim AF, van Laar JAM, Verdijk RM, Paridaens D, van Hagen PM, van Zelm MC. Expansion of blood IgG4+ B, TH2, and regulatory T cells in patients with IgG4-related disease. J Allergy Clin Immunol 2018;141:1831-1843.e10. [PMID: 28830675 DOI: 10.1016/j.jaci.2017.07.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 8.4] [Reference Citation Analysis]
137 Watanabe T, Minaga K, Kamata K, Kudo M, Strober W. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease. Trends Immunol. 2018;39:874-889. [PMID: 30401468 DOI: 10.1016/j.it.2018.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
138 Simó-Perdigó M, Martinez-Valle F. IgG4 related disease. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:107-14. [PMID: 33547020 DOI: 10.1016/j.remn.2020.12.001] [Reference Citation Analysis]
139 Hao M, Liu M, Fan G, Yang X, Li J. Diagnostic Value of Serum IgG4 for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis. Medicine (Baltimore) 2016;95:e3785. [PMID: 27227950 DOI: 10.1097/MD.0000000000003785] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 8.4] [Reference Citation Analysis]
140 Mann S, Seidman MA, Barbour SJ, Levin A, Carruthers M, Chen LY. Recognizing IgG4-related tubulointerstitial nephritis. Can J Kidney Health Dis 2016;3:34. [PMID: 27429760 DOI: 10.1186/s40697-016-0126-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
141 Chen Y, Lin W, Yang H, Wang M, Zhang P, Feng R, Chen H, Peng L, Zhang X, Zhao Y, Zeng X, Zhang F, Zhang W, Lipsky PE. Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease. Arthritis Rheumatol. 2018;70:1853-1865. [PMID: 29781221 DOI: 10.1002/art.40556] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
142 Özdemir-Şimşek Ö, Erfidan G, Arslansoyu-Çamlar S, Alaygut D, Mutlubaş F, Kasap-Demir B. A rare cause of chronic tubulointerstitial nephritis in childhood: Answers. Pediatr Nephrol 2021. [PMID: 34734329 DOI: 10.1007/s00467-021-05326-y] [Reference Citation Analysis]
143 Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4-related disease. Expert Rev Clin Immunol 2017;13:867-75. [PMID: 28701054 DOI: 10.1080/1744666X.2017.1354698] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
144 Sarkar A, Pitchumoni CS. The protean manifestations of IgG4-RD in gastrointestinal disorders. Disease-a-Month 2015;61:493-515. [DOI: 10.1016/j.disamonth.2015.09.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
145 Bradshaw MJ, Bhattacharyya S, Venna N, Cahill JF. Neurologic Manifestations of Systemic Rheumatologic Diseases. In: Rizvi SA, Cahill JF, Coyle PK, editors. Clinical Neuroimmunology. Cham: Springer International Publishing; 2020. pp. 321-42. [DOI: 10.1007/978-3-030-24436-1_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
146 Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag 2016;12:189-99. [PMID: 26929632 DOI: 10.2147/TCRM.S99985] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 7.2] [Reference Citation Analysis]
147 Masunaga A, Ishibashi F, Koh E, Oide T, Sekine Y, Hiroshima K. Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report. Diagn Pathol 2018;13:6. [PMID: 29439708 DOI: 10.1186/s13000-018-0684-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
148 Yoshikawa T, Watanabe T, Minaga K, Kamata K, Kudo M. Cytokines produced by innate immune cells in IgG4-related disease. Mod Rheumatol 2019;29:219-25. [PMID: 30334477 DOI: 10.1080/14397595.2018.1536364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
149 Saitakis G, Chwalisz BK. The neurology of IGG4-related disease. J Neurol Sci 2021;424:117420. [PMID: 33845982 DOI: 10.1016/j.jns.2021.117420] [Reference Citation Analysis]
150 Matsumoto H, Fujita Y, Matsuoka N, Temmoku J, Yashiro-Furuya M, Asano T, Sato S, Watanabe H, Suzuki E, Tsuji S, Fukui S, Umeda M, Iwamoto N, Kawakami A, Migita K. Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD). Arthritis Res Ther 2021;23:148. [PMID: 34030721 DOI: 10.1186/s13075-021-02527-6] [Reference Citation Analysis]
151 Ghably JG, Borthwick T, O'neil TJ, Youngberg GA, Datta AA, Krishnaswamy G. IgG4-related disease: a primer on diagnosis and management. Annals of Allergy, Asthma & Immunology 2015;114:447-54. [DOI: 10.1016/j.anai.2015.04.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
152 Chang AJ, Baron S, Hoffman J, Hicar MD. Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease. Mol Immunol 2022;145:67-77. [PMID: 35303530 DOI: 10.1016/j.molimm.2022.03.011] [Reference Citation Analysis]
153 Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 2020;16:702-14. [PMID: 32939060 DOI: 10.1038/s41584-020-0500-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
154 Maillette de Buy Wenniger LJ, Beuers U. Immunoglobulin G4-related cholangiopathy: clinical and experimental insights. Curr Opin Gastroenterol 2015;31:252-7. [PMID: 25730176 DOI: 10.1097/MOG.0000000000000170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
155 Cortazar FB, Stone JH. IgG4-related disease and the kidney. Nat Rev Nephrol 2015;11:599-609. [DOI: 10.1038/nrneph.2015.95] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
156 Stathopoulos P, Kumar A, Nowak RJ, O'Connor KC. Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis. JCI Insight 2017;2:94263. [PMID: 28878127 DOI: 10.1172/jci.insight.94263] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
157 Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N. Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients. PLoS One 2017;12:e0183844. [PMID: 28915275 DOI: 10.1371/journal.pone.0183844] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 17.2] [Reference Citation Analysis]
158 Grados A, Ebbo M, Jean E, Bernit E, Harlé JR, Schleinitz N. [IgG4-related disease treatment in 2014: Update and literature review]. Rev Med Interne. 2015;36:395-404. [PMID: 25595874 DOI: 10.1016/j.revmed.2014.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
159 Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, Choi HK, Pillai S, Stone JH. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford) 2016;55:1000-8. [PMID: 26888853 DOI: 10.1093/rheumatology/kev438] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 15.5] [Reference Citation Analysis]
160 Della-Torre E, Mattoo H, Mahajan VS, Deshpande V, Krause D, Song P, Pillai S, Stone JH. IgG4-related midline destructive lesion. Ann Rheum Dis 2014;73:1434-6. [PMID: 24651619 DOI: 10.1136/annrheumdis-2014-205187] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
161 Fernández-Codina A, Martínez-Valle F, Pinilla B, López C, DeTorres I, Solans-Laqué R, Fraile-Rodríguez G, Casanovas-Martínez A, López-Dupla M, Robles-Marhuenda Á, Barragán-González MJ, Cid MC, Prieto-González S, Brito-Zerón P, Cruces-Moreno MT, Fonseca-Aizpuru E, López-Torres M, Gil J, Núñez-Fernández MJ, Pardos-Gea J, Salvador-Cervelló G. IgG4-Related Disease: Results From a Multicenter Spanish Registry. Medicine (Baltimore) 2015;94:e1275. [PMID: 26266361 DOI: 10.1097/MD.0000000000001275] [Cited by in Crossref: 76] [Cited by in F6Publishing: 24] [Article Influence: 10.9] [Reference Citation Analysis]
162 Brito-zerón P, Bosch X, Ramos-casals M, Stone JH. IgG4-related disease: Advances in the diagnosis and treatment. Best Practice & Research Clinical Rheumatology 2016;30:261-78. [DOI: 10.1016/j.berh.2016.07.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 7.5] [Reference Citation Analysis]
163 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
164 Backhus J, Neumann C, Perkhofer L, Schulte LA, Mayer B, Seufferlein T, Müller M, Kleger A. A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab. J Clin Med 2021;10:1329. [PMID: 33807051 DOI: 10.3390/jcm10061329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Zhang W, Glaze JH, Wynne D. Combined membranous nephropathy and tubulointerstitial nephritis as a rare renal manifestation of IgG4-related disease: a case-based literature review. CEN Case Rep 2018;7:137-42. [PMID: 29388171 DOI: 10.1007/s13730-018-0311-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
166 Perugino CA, Wallace ZS, Meyersohn N, Oliveira G, Stone JR, Stone JH. Large vessel involvement by IgG4-related disease. Medicine (Baltimore) 2016;95:e3344. [PMID: 27428181 DOI: 10.1097/MD.0000000000003344] [Cited by in Crossref: 95] [Cited by in F6Publishing: 30] [Article Influence: 19.0] [Reference Citation Analysis]
167 Della-torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, Stone JH, Sabbadini MG. Methotrexate for maintenance of remission in IgG4-related disease: Fig. 1. Rheumatology 2015;54:1934-6. [DOI: 10.1093/rheumatology/kev244] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
168 Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171-1177. [PMID: 25667206 DOI: 10.1136/annrheumdis-2014-206605] [Cited by in Crossref: 339] [Cited by in F6Publishing: 280] [Article Influence: 48.4] [Reference Citation Analysis]
169 Oleinika K, Mauri C, Salama AD. Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol 2019;15:11-26. [DOI: 10.1038/s41581-018-0074-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
170 Chwalisz BK, Stone JH. Neuro-ophthalmic complications of IgG4-related disease. Curr Opin Ophthalmol 2018;29:485-94. [PMID: 30199519 DOI: 10.1097/ICU.0000000000000523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
171 Maritati F, Peyronel F, Vaglio A. IgG4-related disease: a clinical perspective. Rheumatology 2020;59:iii123-31. [DOI: 10.1093/rheumatology/kez667] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
172 Wallace ZS, Perugino C, Matza M, Deshpande V, Sharma A, Stone JH. Immunoglobulin G4-related Disease. Clin Chest Med 2019;40:583-97. [PMID: 31376893 DOI: 10.1016/j.ccm.2019.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
173 Kim IY, Eun YH, Jeong H, Park TK, Kim H, Lee J, Jang SY, Kim J, Koh E, Kim D, Cha H. Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases. Int J Rheum Dis 2017;20:1751-62. [DOI: 10.1111/1756-185x.13194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
174 Kleger A, Seufferlein T. [IgG4-associated diseases : State of the art]. Radiologe 2016;56:1035-42. [PMID: 27638824 DOI: 10.1007/s00117-016-0163-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
175 Li J, Liu Z, Zhang P, Lin W, Lu H, Peng Y, Peng L, Zhou J, Wang M, Chen H, Zhao L, Wang L, Qin C, Hu C, Zeng X, Zhao Y, Fei Y, Zhang W. Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease. Front Immunol 2021;12:747076. [PMID: 34603334 DOI: 10.3389/fimmu.2021.747076] [Reference Citation Analysis]
176 Bookhout CE, Rollins-Raval MA. Immunoglobulin G4-Related Lymphadenopathy. Surg Pathol Clin 2016;9:117-29. [PMID: 26940272 DOI: 10.1016/j.path.2015.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
177 Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review. Neurol Neuroimmunol Neuroinflamm 2019;6:e568. [PMID: 31355304 DOI: 10.1212/NXI.0000000000000568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
178 Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191-206. [PMID: 25865251 DOI: 10.1111/cei.12641] [Cited by in Crossref: 114] [Cited by in F6Publishing: 99] [Article Influence: 16.3] [Reference Citation Analysis]
179 Wang Y, Zhao Z, Gao D, Wang H, Liao S, Dong C, Luo G, Ji X, Li Y, Wang X, Zhao Y, Li K, Zhang J, Jin J, Zhang Y, Zhu J, Zhang J, Huang F. Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial. Seminars in Arthritis and Rheumatism 2020;50:1513-20. [DOI: 10.1016/j.semarthrit.2020.01.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
180 Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica 2019;104:444-55. [PMID: 30705099 DOI: 10.3324/haematol.2018.205526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
181 Martín-Nares E, Saavedra-González V, Fagundo-Sierra R, Santinelli-Núñez BE, Romero-Maceda T, Calderón-Vasquez K, Hernandez-Molina G. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease. Sci Rep 2021;11:1832. [PMID: 33469111 DOI: 10.1038/s41598-021-81321-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Abdelrazek M, Stone JH. Neurologic Features of Immunoglobulin G4–Related Disease. Rheumatic Disease Clinics of North America 2017;43:621-31. [DOI: 10.1016/j.rdc.2017.06.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
183 Jiang H, Gao H, Wang Q, Wang M, Wu B. Molecular mechanisms and clinical application of Iguratimod: A review. Biomed Pharmacother 2020;122:109704. [PMID: 31918275 DOI: 10.1016/j.biopha.2019.109704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
184 Puxeddu I, Capecchi R, Pratesi F, Cianchetti S, Tavoni A, Migliorini P. Mediators of angiogenesis and fibrosis in IgG4-related disease. Clin Exp Med 2018;18:245-9. [PMID: 29243036 DOI: 10.1007/s10238-017-0484-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
185 Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, Dagna L, Praderio L, Scotti R, Tresoldi M, Roveri L, Mariani A, Balzano G, Castoldi R, Doglioni C, Sabbadini MG, Della-Torre E. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135-145. [PMID: 26398142 DOI: 10.3109/03009742.2015.1055796] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
186 Chen JH, Deshpande V. IgG4-related Disease and the Liver. Gastroenterology Clinics of North America 2017;46:195-216. [DOI: 10.1016/j.gtc.2017.01.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
187 Besik J, Pirk J, Netuka I, Szarszoi O, Marek T, Urban M, Honsova E, Laco J. Aortic and Mitral Valve Replacement Due to Extensive Inflammatory Immunoglobulin G4–Related Pseudotumor. The Annals of Thoracic Surgery 2015;100:1439-41. [DOI: 10.1016/j.athoracsur.2014.12.051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
188 Della-torre E, Stone JH. “How I manage” IgG4-Related Disease. J Clin Immunol 2016;36:754-63. [DOI: 10.1007/s10875-016-0331-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
189 Wu A, Andrew NH, McNab AA, Selva D. IgG4-Related Ophthalmic Disease: Pooling of Published Cases and Literature Review. Curr Allergy Asthma Rep 2015;15:27. [PMID: 26141575 DOI: 10.1007/s11882-015-0530-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
190 Ryu JH, Yi ES. Immunoglobulin G4-Related Disease and the Lung. Clinics in Chest Medicine 2016;37:569-78. [DOI: 10.1016/j.ccm.2016.04.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
191 Kvitting JPE, Hermansson U, Vanhanen I. Resection of a plasma cell granuloma combining a conventional posterolateral left-sided thoracotomy with a minimally invasive valve approach. Gen Thorac Cardiovasc Surg 2019;67:894-6. [PMID: 30099709 DOI: 10.1007/s11748-018-0986-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
192 Akiyama M, Takeuchi T. IgG4-Related Disease: Beyond Glucocorticoids. Drugs Aging 2018;35:275-87. [PMID: 29546609 DOI: 10.1007/s40266-018-0534-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
193 De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease. Immunol Res 2017;65:386-94. [DOI: 10.1007/s12026-016-8863-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
194 Nikiphorou E, Galloway J, Fragoulis GE. Overview of IgG4-related aortitis and periaortitis. A decade since their first description. Autoimmun Rev 2020;19:102694. [PMID: 33121641 DOI: 10.1016/j.autrev.2020.102694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Maehara T, Moriyama M, Nakamura S. Pathogenesis of IgG4-related disease: a critical review. Odontology 2019;107:127-32. [DOI: 10.1007/s10266-018-0377-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
196 Axelsson S, Magnuson A, Lange A, Alshamari A, Hörnquist EH, Hultgren O. A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex. BMC Immunol 2020;21:14. [PMID: 32197584 DOI: 10.1186/s12865-020-00343-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
197 Farmer JR, DeLelys M. Flow Cytometry as a Diagnostic Tool in Primary and Secondary Immune Deficiencies. Clin Lab Med 2019;39:591-607. [PMID: 31668272 DOI: 10.1016/j.cll.2019.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Akiyama M, Suzuki K, Yamaoka K, Yasuoka H, Takeshita M, Kaneko Y, Kondo H, Kassai Y, Miyazaki T, Morita R, Yoshimura A, Takeuchi T. Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease. Arthritis Rheumatol. 2015;67:2476-2481. [PMID: 25989153 DOI: 10.1002/art.39209] [Cited by in Crossref: 115] [Cited by in F6Publishing: 106] [Article Influence: 16.4] [Reference Citation Analysis]
199 Stathopoulos P, Kumar A, Heiden JAV, Pascual-Goñi E, Nowak RJ, O'Connor KC. Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis. Ann N Y Acad Sci 2018;1412:154-65. [PMID: 29381221 DOI: 10.1111/nyas.13535] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
200 Vasaitis L. IgG4-related disease: A relatively new concept for clinicians. Eur J Intern Med. 2016;27:1-9. [PMID: 26481243 DOI: 10.1016/j.ejim.2015.09.022] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 8.7] [Reference Citation Analysis]
201 Legatowicz-Koprowska M. IgG4-related disease: why is it so important? Cent Eur J Immunol 2018;43:204-8. [PMID: 30135634 DOI: 10.5114/ceji.2018.77391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Newman JH, Shaver A, Sheehan JH, Mallal S, Stone JH, Pillai S, Bastarache L, Riebau D, Allard-Chamard H, Stone WM, Perugino C, Pilkinton M, Smith SA, McDonnell WJ, Capra JA, Meiler J, Cogan J, Xing K, Mahajan VS, Mattoo H, Hamid R, Phillips JA 3rd; Undiagnosed Disease Network. IgG4-related disease: Association with a rare gene variant expressed in cytotoxic T cells. Mol Genet Genomic Med 2019;7:e686. [PMID: 30993913 DOI: 10.1002/mgg3.686] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
203 Akiyama M, Suzuki K, Yasuoka H, Kaneko Y, Yamaoka K, Takeuchi T. Follicular helper T cells in the pathogenesis of IgG4-related disease. Rheumatology 2018;57:236-45. [DOI: 10.1093/rheumatology/kex171] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
204 Ratuszny D, Skripuletz T, Wegner F, Groß M, Falk C, Jacobs R, Ruschulte H, Stangel M, Sühs KW. Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis. Front Neurol 2020;11:602102. [PMID: 33414761 DOI: 10.3389/fneur.2020.602102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
205 Kaur K, Kakkar A, Manchanda S, Chatterjee P, Kaur H, Mishra D, Verma H, Kumar R, Sagar P, Jain D, Bhalla AS. Sinonasal IgG4-related disease: a rare and emerging entity broadening the differential diagnosis in the sinonasal universe. Eur Arch Otorhinolaryngol 2021;278:2883-90. [PMID: 33392765 DOI: 10.1007/s00405-020-06564-w] [Reference Citation Analysis]
206 Schuyler AJ, Wilson JM, Tripathi A, Commins SP, Ogbogu PU, Kruzsewski PG, Barnes BH, McGowan EC, Workman LJ, Lidholm J, Rifas-Shiman SL, Oken E, Gold DR, Platts-Mills TAE, Erwin EA. Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 2018;142:139-148.e12. [PMID: 29678750 DOI: 10.1016/j.jaci.2018.02.049] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
207 Kim HJ, You E, Hong S, Park CJ. A Case of IgG4-related Disease With Bone Marrow Involvement: Bone Marrow Findings and Flow Cytometric Immunophenotyping of Plasma Cells. Ann Lab Med 2021;41:243-6. [PMID: 33063688 DOI: 10.3343/alm.2021.41.2.243] [Reference Citation Analysis]
208 Mehdaoui A, Manoila M, Jaafar M, Mahmoud H, Devin E. [A rare cause of eosinophilic asthma: Hyper-IgG4 syndrome (IgG4-related sclerosing disease)]. Rev Mal Respir 2015;32:941-4. [PMID: 26235334 DOI: 10.1016/j.rmr.2015.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
209 Maehara T, Moriyama M, Nakamura S. Review of a novel disease entity, immunoglobulin G4-related disease. J Korean Assoc Oral Maxillofac Surg 2020;46:3-11. [PMID: 32158675 DOI: 10.5125/jkaoms.2020.46.1.3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
210 Gökçay Canpolat A, Cinel M, Dizbay Sak S, Taşkaldıran I, Korkmaz H, Demir Ö, Ersoy R, Dağdelen S, Berker D, Dalva K, Bahçecioğlu Mutlu AB, Erdoğan MF. Long-Term Outcomes of Tamoxifen Citrate Therapy and Histo- and Immunopathological Properties in Riedel Thyroiditis. Eur Thyroid J 2021;10:248-56. [PMID: 34178711 DOI: 10.1159/000512017] [Reference Citation Analysis]
211 AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol 2018;17:183-92. [PMID: 29413316 DOI: 10.1016/S1474-4422(17)30471-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 9.3] [Reference Citation Analysis]
212 Iaccarino L, Talarico R, Scirè CA, Amoura Z, Burmester G, Doria A, Faiz K, Frank C, Hachulla E, Hie M, Launay D, Montecucco C, Monti S, Mouthon L, Tincani A, Toniati P, Van Hagen PM, Van Vollenhoven RF, Bombardieri S, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Alexander T. IgG4-related diseases: state of the art on clinical practice guidelines. RMD Open 2018;4:e000787. [PMID: 30729031 DOI: 10.1136/rmdopen-2018-000787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
213 Hubers LM, Beuers U. How to Diagnose Immunoglobulin G4-Associated Cholangitis: The Jack-of-All-Trades in the Biliary Tract. Viszeralmedizin. 2015;31:185-188. [PMID: 26468313 DOI: 10.1159/000431028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
214 Hicar MD. Antibodies and Immunity During Kawasaki Disease. Front Cardiovasc Med 2020;7:94. [PMID: 32671098 DOI: 10.3389/fcvm.2020.00094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
215 Wolfson AR, Hamilos DL. Recent advances in understanding and managing IgG4-related disease. F1000Res 2017;6:F1000 Faculty Rev-185. [PMID: 28299186 DOI: 10.12688/f1000research.9399.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
216 Haldar D, Cockwell P, Richter AG, Roberts KJ, Hirschfield GM. An overview of the diagnosis and management of immunoglobulin G4-related disease. CMAJ. 2016;188:953-961. [PMID: 27325130 DOI: 10.1503/cmaj.151402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
217 Fernández-codina A, Pinilla B, Pinal-fernández I, López C, Fraile-rodríguez G, Fonseca-aizpuru E, Carballo I, Brito-zerón P, Feijóo-massó C, López-dupla M, Cid MC, Martínez-valle F. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index. Joint Bone Spine 2018;85:721-6. [DOI: 10.1016/j.jbspin.2018.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
218 Mombaerts I, Bilyk JR, Rose GE, McNab AA, Fay A, Dolman PJ, Allen RC, Devoto MH, Harris GJ; Expert Panel of the Orbital Society. Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach. JAMA Ophthalmol 2017;135:769-76. [PMID: 28570731 DOI: 10.1001/jamaophthalmol.2017.1581] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 10.4] [Reference Citation Analysis]
219 Nies JF, Krusche M. [Immunoglobulin-G4-related disease]. Z Rheumatol 2022. [PMID: 35767095 DOI: 10.1007/s00393-022-01229-x] [Reference Citation Analysis]
220 Papa BM, Prince HM, McNab AA, McKelvie P. IgG4-related ophthalmic disease in association with adult-onset asthma and periocular xanthogranuloma: a case report. Orbit 2021;:1-6. [PMID: 34493168 DOI: 10.1080/01676830.2021.1973512] [Reference Citation Analysis]
221 Tang J, Cai S, Ye C, Dong L. Biomarkers in IgG4-related disease: A systematic review. Semin Arthritis Rheum. 2020;50:354-359. [PMID: 31280934 DOI: 10.1016/j.semarthrit.2019.06.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
222 Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E, Saadoun D, Audia S, Rigolet A, Terrier B, Perlat A, Guillaud C, Renou F, Bernit E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N. Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series. Medicine (Baltimore) 2017;96:e6205. [PMID: 28272212 DOI: 10.1097/MD.0000000000006205] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 6.6] [Reference Citation Analysis]
223 Kotha S, Tritto G, Wong T, Berry P. IgG4-related disease: long-term natural history and management of a relapsing multisystem disease entity. BMJ Case Rep 2017;2017:bcr-2017-219897. [PMID: 28716871 DOI: 10.1136/bcr-2017-219897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Sokol EV, Vasilyev VI, Palshina SG, Kokosadze NV, Probatova NA, Kovrigina AM, Safonova TN, Rodionova EB, Gaiduk IV, Selifanova EI. [Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm]. Ter Arkh 2019;91:40-8. [PMID: 32598675 DOI: 10.26442/00403660.2019.05.000236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Bledsoe JR, Della-Torre E, Rovati L, Deshpande V. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS 2018;126:459-76. [PMID: 29924455 DOI: 10.1111/apm.12845] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 12.0] [Reference Citation Analysis]
226 Kamisawa T, Zen Y, Nakazawa T, Okazaki K. Advances in IgG4-related pancreatobiliary diseases. Lancet Gastroenterol Hepatol. 2018;3:575-585. [PMID: 30047448 DOI: 10.1016/s2468-1253(18)30121-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
227 Fernández-codina A, Orozco-gálvez O, Martínez-valle F. Therapeutic Options in IgG4-Related Disease. Curr Treat Options in Rheum 2020;6:191-204. [DOI: 10.1007/s40674-020-00147-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Zhang P, Wang M, Chen Y, Li J, Liu Z, Lu H, Fei Y, Feng R, Zhao Y, Zeng X, Zhang W. Expanded CD4+CXCR5-PD-1+ peripheral T helper like cells and clinical significance in IgG4-related disease. Clin Immunol 2022;:108975. [PMID: 35276322 DOI: 10.1016/j.clim.2022.108975] [Reference Citation Analysis]
229 Kakuchi Y, Yamada K, Ito K, Hara S, Fujii H, Yamagishi M, Kawano M. Analysis of IgG4-positive clones in affected organs of IgG4-related disease. Modern Rheumatology 2016;26:923-8. [DOI: 10.3109/14397595.2016.1159385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
230 Szczawinska-Poplonyk A, Wojsyk-Banaszak I, Jonczyk-Potoczna K, Breborowicz A. Pulmonary manifestation of immunoglobulin G4-related disease in a 7-year-old immunodeficient boy with Epstein-Barr virus infection: a case report. Ital J Pediatr 2016;42:58. [PMID: 27277432 DOI: 10.1186/s13052-016-0269-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
231 Melenotte C, Seguier J, Ebbo M, Kaphan E, Bernit E, Saillier L, Audoin B, Feyeux D, Daniel L, Roche P, Graillon T, Dufour H, Boutière C, Girard N, Closs-prophette F, Guillaud C, Tieulié N, Regent A, Harlé JR, Hamidou M, Mekinian A, Grados A, Schleinitz N. Clinical presentation, treatment and outcome of IgG4-related pachymeningitis: From a national case registry and literature review. Seminars in Arthritis and Rheumatism 2019;49:430-7. [DOI: 10.1016/j.semarthrit.2019.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
232 Wang L, Zhang P, Wang M, Feng R, Lai Y, Peng L, Fei Y, Zhang X, Zhao Y, Zeng X, Zhang F, Zhang W. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther 2018;20:65. [PMID: 29636109 DOI: 10.1186/s13075-018-1567-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
233 Vashi B, Khosroshahi A. IgG4-Related Disease with Emphasis on Its Gastrointestinal Manifestation. Gastroenterol Clin North Am. 2019;48:291-305. [PMID: 31046976 DOI: 10.1016/j.gtc.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
234 Witte T. [Immunological principles of IgG4 related diseases]. Z Rheumatol 2016;75:660-5. [PMID: 27316974 DOI: 10.1007/s00393-016-0123-1] [Reference Citation Analysis]
235 Quattrocchio G, Roccatello D. IgG4-related nephropathy. J Nephrol. 2016;29:487-493. [PMID: 26972314 DOI: 10.1007/s40620-016-0279-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
236 Anand P, Chwalisz BK. Inflammatory Disorders of the Skull Base: a Review. Curr Neurol Neurosci Rep 2019;19. [DOI: 10.1007/s11910-019-1016-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Campochiaro C, Della-torre E, Lanzillotta M, Bozzolo E, Baldissera E, Milani R, Arcidiacono PG, Crippa S, Falconi M, Dagna L. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease. European Journal of Internal Medicine 2020;74:92-8. [DOI: 10.1016/j.ejim.2019.12.029] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]